Comparing two malaria vaccine approaches in healthy adults
Treatments studied
Part of Infections clinical trials.
This study tests two different malaria vaccines to see which is safer and works better. Participants will receive one of the vaccines and then be exposed to a safe form of the malaria parasite to check if it protects them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18-45 and general good health
- Live in or near Tübingen, Germany for the entire study
- For women: agree to use effective birth control and have negative pregnancy tests
- No history of malaria in the last 5 years and no prior malaria vaccine
- Willing to take antimalarial drugs and be observed overnight after the challenge
- No HIV, weakened immune system, blood disorders, or certain chronic conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new long-acting injection to prevent malaria. It checks safety and how the body handles the drug in healthy adults and adolescents in Rwanda.
This study gives healthy adults who have never had malaria a controlled infection with the parasite that causes malaria, to see if it is safe and if mosquitoes can pick up the parasite from them. It may help develop new ways to prevent malaria.
This study tests a new combination of three malaria drugs in healthy adults to see how safe they are and how the body handles them. It helps find the right dose for future patients.
This study screens healthy adults to see who can join future malaria vaccine or investigational malaria drug studies, including a controlled malaria exposure. It may help researchers test safer vaccines/drugs, but participation requires good health and strict medical eligibility.
This study tests a new malaria vaccine (called R21/MM) given in different doses and forms. If you qualify, you'll help find a better way to protect against malaria.
This study tests an experimental malaria vaccine in healthy adults. The vaccine is given along with other medicines and a controlled exposure to mosquito bites to see how well it protects against malaria.
Hear when a new Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.